Medicenna Therapeutics Corp.
MDNA.TO
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 15.00M | 17.28M | 20.85M | 22.52M | 26.03M |
| Total Receivables | 859.30K | 1.88M | 991.80K | 1.10M | 870.90K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 694.40K | 444.60K | 408.70K | 569.20K | 819.10K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 16.55M | 19.60M | 22.25M | 24.19M | 27.72M |
|
|
|||||
| Total Current Assets | 16.55M | 19.60M | 22.25M | 24.19M | 27.72M |
| Net Property, Plant & Equipment | 104.10K | 110.60K | 121.60K | 143.60K | 20.50K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 36.70K | 36.20K | 36.80K | 40.00K | 40.20K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 16.70M | 19.75M | 22.41M | 24.37M | 27.78M |
|
|
|||||
| Total Accounts Payable | 2.34M | 1.88M | 1.31M | 1.47M | 2.58M |
| Total Accrued Expenses | 973.00K | 1.17M | 871.50K | 626.20K | 358.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 42.50K | 34.10K | 27.80K | 23.70K | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | 8.12M |
| Total Other Current Liabilities | -- | -- | -- | -- | 8.12M |
| Total Current Liabilities | 3.35M | 3.09M | 2.21M | 2.12M | 11.06M |
|
|
|||||
| Total Current Liabilities | 3.35M | 3.09M | 2.21M | 2.12M | 11.06M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 76.30K | 82.80K | 93.10K | 106.60K | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.53M | 3.29M | 7.98M | 7.30M | -- |
| Total Liabilities | 5.96M | 6.46M | 10.28M | 9.53M | 11.06M |
|
|
|||||
| Common Stock & APIC | 101.03M | 88.71M | 88.28M | 92.14M | 89.94M |
| Retained Earnings | -90.32M | -82.27M | -83.01M | -84.57M | -80.43M |
| Treasury Stock & Other | 25.70K | 6.84M | 6.86M | 7.27M | 7.21M |
| Total Common Equity | 10.74M | 13.28M | 12.13M | 14.84M | 16.72M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 10.74M | 13.28M | 12.13M | 14.84M | 16.72M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 10.74M | 13.28M | 12.13M | 14.84M | 16.72M |
|
|
|||||